USD
Cellular biosensor for diagnostics of the autoimmune human pathology pp232 in New York online-store Global Innovations | Buy Cellular biosensor for diagnostics of the autoimmune human pathology PP232 New York (USA) | Global Innovations : Allbiz
Reviews: 0
Global Innovations
+1 (646) 905-01-09
Cellular biosensor for diagnostics of the autoimmune human pathology PP232
  • Cellular biosensor for diagnostics of the autoimmune human pathology PP232

Cellular biosensor for diagnostics of the autoimmune human pathology PP232

In stock
Description

Purpose and scope

The biosensor is intended to determine the microcourses of cytotoxic factors in human serum. The development can be applied in the institutions of the Ministry of Health of Ukraine.

The essence of the development

A highly sensitive cellular biosensor has been developed to detect cytotoxic compounds in patients with low concentrations (which are difficult to detect by analytical methods).

The emergencee of these cytotoxic compounds in the body triggers a cascade of immunological reactions that lead to the formation of pathologies, in particular myasthenia. The principle of the diagnostic method is based on the fact that cytotoxic compounds , interact with the cellular biosensor and lead to changes in its characteristics. The results are processed according to the developed program, and on the basis of this conclusion is made about the presence of autoimmune pathology and the stage of its development. Testing time is from 30 to 60 minutes. For analysis, 50 micro liters of patient blood serum is required.

Intellectual Property Protection Status

Patent of Ukraine is received.

Market demand

Development is in demand in the Ukrainian market.

The state of readiness of development

A sample was created.

Information is up-to-date: 10.04.2020

Read more

Unbelievable price on Cellular biosensor for diagnostics of the autoimmune human pathology PP232 in New York (USA) company Global Innovations.
LiveInternet